RxSight, Inc. revised earnings guidance for the year 2023. For the year, the company expects revenue guidance range of $79.0 million to $84.0 million, representing implied growth of 61% to 71% compared to 2022, up from prior guidance of $78.0 million to $83.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.3 USD | -2.00% | -5.91% | +42.26% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.26% | 2.28B | |
-6.51% | 178B | |
-1.13% | 107B | |
-2.50% | 67.04B | |
-7.10% | 47.23B | |
+11.32% | 44.62B | |
+9.25% | 42.5B | |
+14.78% | 29.99B | |
+15.97% | 25.22B | |
-7.18% | 24.14B |
- Stock Market
- Equities
- RXST Stock
- News RxSight, Inc.
- RxSight, Inc. Revises Earnings Guidance for the Year 2023